When and How to Divide to Conquer: Personalised Medicine in Gastrointestinal Cancers".
Sadanandam has classified different tumor types with different prognostic, cell-of-origin/phenotypes and therapeutic responses including pancreatic and colorectal tumours and stroma (in multiple Nature Medicines, Cancer Discovery and other reputed journals). Recently, he has published studies showing how to develop and use clinically relevant biomarker assays in gastrointestinal cancers. He also has shown how personaliseed preclinical trials can be done using in vitro and in vivo models. These pioneering studies are being explored by clinicians and cancer researchers for potential applications for patient benefits
Date:
10 February 2020, 11:00 (Monday, 4th week, Hilary 2020)
Venue:
Old Road Campus Research Building, Headington OX3 7DQ
Venue Details:
10.71a
Speaker:
Anguraj Sadanandam (Institute of Cancer Research (ICR), London)
Organising department:
Department of Oncology
Organiser:
Gillian Roberts (University of Oxford)
Organiser contact email address:
Gillian.roberts@oncology.ox.ac.uk
Host:
Prof Mark Middleton
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Gillian Roberts
